cas 1396785-08-2|| where to buy N-(3,3-diphenylpropyl)-2,4-dioxo-3-[(thiophen-2-yl)methyl]-1,2,3,4-tetrahydropyrimidine-5-carboxamide

Nombre del producto:N-(3,3-diphenylpropyl)-2,4-dioxo-3-[(thiophen-2-yl)methyl]-1,2,3,4-tetrahydropyrimidine-5-carboxamide

IUPAC Name:N-(3,3-diphenylpropyl)-2,4-dioxo-3-[(thiophen-2-yl)methyl]-1,2,3,4-tetrahydropyrimidine-5-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1396785-08-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1396785-08-2; Fórmula molecular:C25H23N3O3S; Punto de fusión:-; Código de sonrisas:O=C(NCCC(C1=CC=CC=C1)C1=CC=CC=C1)C1=CNC(=O)N(CC2=CC=CS2)C1=O; Densidad:

: Número de catálogo:CM950326; Peso molecular:445.54; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Thiophenes; Thiophene is a five-membered heterocyclic compound containing a sulfur heteroatom with the molecular formula C4H4S. Thiophene is aromatic and is very similar to benzene; electrophilic substitution reaction is easier than benzene, and it is mainly substituted at the 2-position. Thiophene ring system has certain stability to oxidant.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.